Nucleoside derivatives and therapeutic use thereof

Details for Australian Patent Application No. 2005230676 (hide)

Owner Rexahn Corporation

Inventors Lee, Young B.; Jeong, Lak S.; Lee, Sang K.; Choi, Won J.; Ahn, Chang H.

Agent Freehills

Pub. Number AU-B-2005230676

PCT Pub. Number WO2005/097757

Priority 60/558,141 01.04.04 US

Filing date 1 April 2005

Wipo publication date 20 October 2005

Acceptance publication date 7 October 2010

International Classifications

C07D 239/54 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

A61K 31/513 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. cytosine

C07D 239/46 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 239/553 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

Event Publications

26 October 2006 PCT application entered the National Phase

  PCT publication WO2005/097757 Priority application(s): WO2005/097757

7 October 2010 Application Accepted

  Published as AU-B-2005230676

3 February 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005230677-Composition and method for inhibiting platelet aggregation

2005230669-Cartridged ammunition, especially of an average caliber